Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Transfusion of Autologous Umbilical Cord Blood to Reverse Hyperglycemia in Children with Type 1 Diabetes - A Pilot Study
2007-007694-23Phase 2Terminated
- Sponsor
- Forschergruppe Diabetes
- Start
- Mar 2008
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of Nabelschnurblut Vita 34 in diabetes mellitus type 1 (T1D), sponsored by Forschergruppe Diabetes. Primary endpoints: Change in HbA1c over time, Change in islet-related autoantibody levels and 4 more. Started Mar 2008; status: terminated.
02
Drugs
Nabelschnurblut Vita 34
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2007-007694-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-007694-23.